CohBar, Inc. CohBar, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Science
    • Overview
    • Platform Technology
    • Pipeline
  • News & Media
    • Press Releases
    • Publications
    • Events
    • Media
    • Newsroom
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers
  • Search

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications
  • Events
  • Media
  • Newsroom

CohBar to Present at the 33rd Annual ROTH Conference

Mar 2, 2021

CohBar to Present at the H.C. Wainwright Global Life Sciences Conference

Feb 25, 2021

CohBar to Present at the BIO CEO & Investor Digital Conference

Feb 9, 2021

CohBar to Present at the 3rd Annual Longevity Therapeutics Conference

Jan 20, 2021

CohBar Announces Preclinical Collaboration with NIAID to Evaluate Potential of CB5064 Analogs for Treatment of COVID-19 ARDS

Jan 11, 2021

CohBar Confirms Efficacy of Novel Apelin Agonists in Acute Respiratory Distress Syndrome (ARDS) Model

Dec 9, 2020

CohBar to Present at the Piper Sandler 32nd Annual Healthcare Conference

Nov 19, 2020

CohBar Reports Third Quarter 2020 Financial Results and Provides Business Update

Nov 16, 2020

CohBar to Announce 2020 Third Quarter Financial Results and Provide Business Update on November 16, 2020

Nov 2, 2020

CohBar to Host Key Opinion Leader Meeting on Antifibrotic Peptides for the Potential Treatment of Idiopathic Pulmonary Fibrosis

Oct 29, 2020
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...14
© 2021 CohBar, Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap